Approval · Notice of Compliance 14390 · 2013
ALEVE: Notice of Compliance 14390
Issued April 24, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14390
- Date
- April 24, 2013
- Company
- Bayer Inc Consumer CareMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removing carton (keeping bottle only) for 250 caplet package only. Removing indication statement from bottle due to space limitations
- Therapeutic class
- Analgesic - antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALEVE | Not yet assigned | — |
Medicinal ingredients
- NAPROXEN SODIUM 220 MG per TAB